About Abalone Bio
Abalone Bio is a San Francisco Bay Area, preclinical-stage biotechnology company developing antibody drugs for G protein-coupled receptors (GPCRs), ion channels and other membrane protein targets. We are developing our own therapeutics as well as partnering with pharmaceutical companies to discover drug candidates for their targets.
At the core of our company is a functional antibody discovery platform comprising a synthetic biology-powered cell-based enrichment component and an NGS-powered computational selection component. We directly search for antibodies that can modulate the function of receptor targets, rather than first finding binders and then screening that subset for function. We find ultra-rare antibodies that have unique functional properties that enable us to address previously untreatable diseases.
We’ve used our platform to develop a panel of novel anti-inflammatory antibody drug candidates that we are testing in a variety of animal disease models, and are developing candidates for other previously undruggable target receptors.